-
1 Comment
ImExHS Limited is currently in a long term uptrend where the price is trading 1.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
ImExHS Limited's total revenue sank by 0.0% to $3M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 74.3% to $-525K since the same quarter in the previous year.
Based on the above factors, ImExHS Limited gets an overall score of 3/5.
ISIN | None |
---|---|
Industry | |
Sector | |
CurrencyCode | EUR |
Exchange | F |
Target Price | None |
---|---|
Dividend Yield | 0.0% |
PE Ratio | None |
Beta | 1.3 |
Market Cap | 26M |
ImExHS Limited operates as an imaging software as a service and ancillary service provider in Australia and internationally. It is involved in developing and selling Hiruko software platform that comprises radiology information system, which manages the workflow management system with a patient data and image distribution system, as well as picture archiving and communication system that allows healthcare organization to capture, store, view, and share radiology images. The company was founded in 2012 and is headquartered in Mascot, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for A4B.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024